Department of Pharmaceutical Science, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, China.
School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, China.
J Control Release. 2017 Feb 28;248:33-44. doi: 10.1016/j.jconrel.2017.01.017. Epub 2017 Jan 11.
Chemical enhancers are widely used for facilitating drug penetration in transdermal drug delivery system (TDDS). However, there is a lack of knowledge about how the enhancement effect changes over time. In this study, on the basis of kinetic parameters of enhancement effect, molecular details of the dynamic enhancement process was described and a new hypothesis of the recovery mechanism of the skin barrier function was proposed. Using pretreated skin and flurbiprofen patch, the effects of Azone (AZ) and menthyl decanoate (MT-10) were evaluated with in vitro permeation experiment and further confirmed by confocal laser scanning microscopy (CLSM) and TEWL. The results showed that the enhancement ratio (ER) increased firstly, then reached a plateau and finally decreased. The enhancement effect of MT-10 was slower (T>T), weaker (ER<ER) and shorter (T<T) than that of AZ. According to the results of CLSM, ATR-FTIR and molecular dynamic simulation, the dynamic enhancement effect was caused by the variation of the diffusion coefficient of intercellular lipid in the stratum corneum (SC), which was dependent on the affinity between enhancers and lipid. Moreover, the skin barrier function recovered although a large amount of enhancers still existed in the SC. Additionally, according to the results of ATR-FTIR, molecular docking and skin retention study, the dynamic effect of AZ on the skin protein only induced skin irritation but showed no influence on drug penetration, so did the amount of the enhancer. In conclusion, dynamic enhancement effect was caused by the dynamic effect of the enhancer on the SC intercellular lipid, and the skin barrier function recovered by accepting the enhancer as a new component of the lipid bilayer.
化学增强剂广泛用于促进经皮给药系统(TDDS)中的药物渗透。然而,对于增强效果随时间的变化如何,人们知之甚少。在这项研究中,基于增强效果的动力学参数,描述了动态增强过程的分子细节,并提出了皮肤屏障功能恢复机制的新假设。使用预处理皮肤和氟比洛芬贴剂,通过体外渗透实验评估了氮酮(AZ)和薄荷醇癸酸酯(MT-10)的作用,并通过共聚焦激光扫描显微镜(CLSM)和 TEWL 进一步证实。结果表明,增强比(ER)先增加,然后达到平台,最后降低。MT-10 的增强效果较慢(T>T),较弱(ER<ER),持续时间较短(T<T)。根据 CLSM、ATR-FTIR 和分子动力学模拟的结果,动态增强效果是由角质层(SC)细胞间脂质扩散系数的变化引起的,这取决于增强剂与脂质的亲和力。此外,尽管大量增强剂仍存在于 SC 中,皮肤屏障功能仍会恢复。此外,根据 ATR-FTIR、分子对接和皮肤保留研究的结果,AZ 对皮肤蛋白的动态作用仅引起皮肤刺激,对药物渗透没有影响,增强剂的量也是如此。总之,动态增强效果是由增强剂对 SC 细胞间脂质的动态作用引起的,皮肤屏障功能通过接受增强剂作为脂质双层的新成分而恢复。